Skip to content

A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses

A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses: A Pilot Study

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00826488
Enrollment
136
Registered
2009-01-22
Start date
2009-03-31
Completion date
2014-12-31
Last updated
2015-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibrocystic Disease of Breast, Breast Cancer

Keywords

Breast Cancer, Mammography, Benign masses, Breast Lump, Breast Biopsy, Breast Mass

Brief summary

The purpose of this study is to compare conventional breast imaging and diagnostic work-up (2 dimensional imaging) to digital breast tomosynthesis (3 dimensional imaging) in the appearance of non-calcified breast masses. It is thought that non-calcified breast masses will be better visualized with the new 3D technology.

Interventions

Women with a positive screening mammogram called back for additional views will be asked to undergo an additional Digital Breast Tomosynthesis (3D mammogram) on the affected breast. Radiation dose is somewhat less than that of a screening mammogram.

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Female * Any race or ethnicity * At least 35 years old * Prior screening or full diagnostic mammogram at Barnes Jewish Breast Health Center

Exclusion criteria

* Unable or unwilling to undergo informed consent * Subjects who have breast implants * Subjects who are unable or unwilling to tolerate compression * Subjects who are pregnant or who think they may be pregnant * Subjects who are currently lactating * Men * Women less than 35 years old * Women greater than 80 years old * Subjects whose breasts are larger than the tomosynthesis detector

Design outcomes

Primary

MeasureTime frame
It is anticipated that out of 100 subjects recalled for additional breast imaging that 10 women will be recalled for biopsy. By adding 2D & 3D imaging, it is anticipated that 30 subjects out of 100 will have needed no workup.9 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026